Industry: Chemical & Material
Published Date: 2026-07-14
Pages: 135 Pages
Report ld: 6890746
Request Sample
Customized Report
1,3-Cyclopentanedione Market Size(US$)

CAGR 2026-2032
4.8%
Market Size,2032
USD 37.9
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for 1,3-Cyclopentanedione was estimated to be worth US$ 27.42 million in 2025 and is projected to reach US$ 37.9 million, growing at a CAGR of 4.8% from 2026 to 2032.
1,3-Cyclopentanedione (CAS 3859-41-4) is a white to brown crystalline powder with a molecular formula of C5H6O2, mainly used as an intermediate in organic synthesis.
1,3-Cyclopentanedione, is a significant organic compound with wide applications in the chemical, pharmaceutical, and agrochemical industries. The market demand for this compound has been steadily increasing, leading to a growing market size. As a versatile synthetic intermediate, it finds extensive use in pharmaceutical synthesis and pesticide manufacturing, thanks to its distinctive chemical structure. Looking ahead, with ongoing technological innovations in the chemical industry and rising demand, 1,3-cyclopentanedione is poised for further development, exploring new application areas and contributing to the continuous growth of the industry.
This report provides a comprehensive view of the global market for 1,3-Cyclopentanedione, covering total sales volume, sales revenue, pricing, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.
The 1,3-Cyclopentanedione market size, estimations, and forecasts are presented in terms of sales volume (Kiloton) and revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding 1,3-Cyclopentanedione.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the scope of the report and the global market size (value, volume, and price). It also summarizes market dynamics and Recent Developments; identifies key drivers and restraints; outlines challenges and risks for manufacturers; reviews relevant industry policies and U.S. tariff implications.
Chapter 2: Provides a detailed analysis of the 1,3-Cyclopentanedione manufacturers' competitive landscape—including pricing, sales and revenue shares, Recent Developments plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents 1,3-Cyclopentanedione sales and revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents 1,3-Cyclopentanedione sales and revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product sales, revenue, pricing, gross margin, product portfolios, Recent Developments, etc.
Chapter 8: Analyzes the industry value chain, including upstream suppliers and downstream applications/customers.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 1,3-Cyclopentanedione Product Introduction
1.2 Global 1,3-Cyclopentanedione Market Size Forecast
1.2.1 Global 1,3-Cyclopentanedione Sales Value (2021–2032)
1.2.2 Global 1,3-Cyclopentanedione Sales Volume (2021–2032)
1.2.3 Global 1,3-Cyclopentanedione Sales Price (2021–2032)
1.3 1,3-Cyclopentanedione Market Trends & Drivers
1.3.1 1,3-Cyclopentanedione Industry Trends
1.3.2 1,3-Cyclopentanedione Market Drivers & Opportunities
1.3.3 1,3-Cyclopentanedione Market Challenges
1.3.4 1,3-Cyclopentanedione Market Restraints
1.3.5 Impact of U.S. Tariffs
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global 1,3-Cyclopentanedione Players Revenue Ranking (2025)
2.2 Global 1,3-Cyclopentanedione Revenue by Company (2021–2026)
2.3 Global 1,3-Cyclopentanedione Sales Volume Ranking of Players (2025)
2.4 Global 1,3-Cyclopentanedione Sales Volume by Company (2021–2026)
2.5 Global 1,3-Cyclopentanedione Average Price by Company (2021–2026)
2.6 Key Manufacturers 1,3-Cyclopentanedione Manufacturing Base and Headquarters
2.7 Key Manufacturers 1,3-Cyclopentanedione Product Offerings
2.8 Key Manufacturers Start of Mass Production of 1,3-Cyclopentanedione
2.9 1,3-Cyclopentanedione Market Competitive Analysis
2.9.1 1,3-Cyclopentanedione Market Concentration Rate (2021–2026)
2.9.2 Global 5 and 10 Largest Manufacturers by 1,3-Cyclopentanedione Revenue in 2025
2.9.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on 1,3-Cyclopentanedione revenue, 2025
2.10 Mergers & Acquisitions and Expansion
3 Segmentation 1,3-Cyclopentanedione Market Classification
3.1 Introduction by Type
3.1.1 Purity above 98%
3.1.2 Purity above 99%
3.1.3 Others
3.1.4 Global 1,3-Cyclopentanedione Sales Value by Type
3.1.4.1 Global 1,3-Cyclopentanedione Sales Value by Type (2021 vs 2025 vs 2032)
3.1.4.2 Global 1,3-Cyclopentanedione Sales Value, by Type (2021–2032)
3.1.4.3 Global 1,3-Cyclopentanedione Sales Value, by Type (%), 2021–2032
3.1.5 Global 1,3-Cyclopentanedione Sales Volume by Type
3.1.5.1 Global 1,3-Cyclopentanedione Sales Volume by Type (2021 vs 2025 vs 2032)
3.1.5.2 Global 1,3-Cyclopentanedione Sales Volume, by Type (2021–2032)
3.1.5.3 Global 1,3-Cyclopentanedione Sales Volume, by Type (%), 2021–2032
3.1.6 Global 1,3-Cyclopentanedione Average Price by Type (2021–2032)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Industrial
4.1.2 Laboratories
4.1.3 Others
4.2 Global 1,3-Cyclopentanedione Sales Value by Application
4.2.1 Global 1,3-Cyclopentanedione Sales Value by Application (2021 vs 2025 vs 2032)
4.2.2 Global 1,3-Cyclopentanedione Sales Value, by Application (2021–2032)
4.2.3 Global 1,3-Cyclopentanedione Sales Value, by Application (%), 2021–2032
4.3 Global 1,3-Cyclopentanedione Sales Volume by Application
4.3.1 Global 1,3-Cyclopentanedione Sales Volume by Application (2021 vs 2025 vs 2032)
4.3.2 Global 1,3-Cyclopentanedione Sales Volume, by Application (2021–2032)
4.3.3 Global 1,3-Cyclopentanedione Sales Volume, by Application (%), 2021–2032
4.4 Global 1,3-Cyclopentanedione Average Price by Application (2021–2032)
5 Segmentation by Region
5.1 Global 1,3-Cyclopentanedione Sales Value by Region
5.1.1 Global 1,3-Cyclopentanedione Sales Value by Region: 2021 vs 2025 vs 2032
5.1.2 Global 1,3-Cyclopentanedione Sales Value by Region (2021–2026)
5.1.3 Global 1,3-Cyclopentanedione Sales Value by Region (2027–2032)
5.1.4 Global 1,3-Cyclopentanedione Sales Value by Region (%), 2021–2032
5.2 Global 1,3-Cyclopentanedione Sales Volume by Region
5.2.1 Global 1,3-Cyclopentanedione Sales Volume by Region: 2021 vs 2025 vs 2032
5.2.2 Global 1,3-Cyclopentanedione Sales Volume by Region (2021–2026)
5.2.3 Global 1,3-Cyclopentanedione Sales Volume by Region (2027–2032)
5.2.4 Global 1,3-Cyclopentanedione Sales Volume by Region (%), 2021–2032
5.3 Global 1,3-Cyclopentanedione Average Price by Region (2021–2032)
5.4 North America
5.4.1 North America 1,3-Cyclopentanedione Sales Value, 2021–2032
5.4.2 North America 1,3-Cyclopentanedione Sales Value by Country (%), 2025 vs 2032
5.5 Europe
5.5.1 Europe 1,3-Cyclopentanedione Sales Value, 2021–2032
5.5.2 Europe 1,3-Cyclopentanedione Sales Value by Country (%), 2025 vs 2032
5.6 Asia Pacific
5.6.1 Asia Pacific 1,3-Cyclopentanedione Sales Value, 2021–2032
5.6.2 Asia Pacific 1,3-Cyclopentanedione Sales Value by Region (%), 2025 vs 2032
5.7 South America
5.7.1 South America 1,3-Cyclopentanedione Sales Value, 2021–2032
5.7.2 South America 1,3-Cyclopentanedione Sales Value by Country (%), 2025 vs 2032
5.8 Middle East & Africa
5.8.1 Middle East & Africa 1,3-Cyclopentanedione Sales Value, 2021–2032
5.8.2 Middle East & Africa 1,3-Cyclopentanedione Sales Value by Country (%), 2025 vs 2032
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions 1,3-Cyclopentanedione Sales Value Growth Trends, 2021 vs 2025 vs 2032
6.2 Key Countries/Regions 1,3-Cyclopentanedione Sales Value and Sales Volume
6.2.1 Key Countries/Regions 1,3-Cyclopentanedione Sales Value, 2021–2032
6.2.2 Key Countries/Regions 1,3-Cyclopentanedione Sales Volume, 2021–2032
6.3 United States
6.3.1 United States 1,3-Cyclopentanedione Sales Value, 2021–2032
6.3.2 United States 1,3-Cyclopentanedione Sales Value by Type (%), 2025 vs 2032
6.3.3 United States 1,3-Cyclopentanedione Sales Value by Application, 2025 vs 2032
6.4 Europe
6.4.1 Europe 1,3-Cyclopentanedione Sales Value, 2021–2032
6.4.2 Europe 1,3-Cyclopentanedione Sales Value by Type (%), 2025 vs 2032
6.4.3 Europe 1,3-Cyclopentanedione Sales Value by Application, 2025 vs 2032
6.5 China
6.5.1 China 1,3-Cyclopentanedione Sales Value, 2021–2032
6.5.2 China 1,3-Cyclopentanedione Sales Value by Type (%), 2025 vs 2032
6.5.3 China 1,3-Cyclopentanedione Sales Value by Application, 2025 vs 2032
6.6 Japan
6.6.1 Japan 1,3-Cyclopentanedione Sales Value, 2021–2032
6.6.2 Japan 1,3-Cyclopentanedione Sales Value by Type (%), 2025 vs 2032
6.6.3 Japan 1,3-Cyclopentanedione Sales Value by Application, 2025 vs 2032
6.7 South Korea
6.7.1 South Korea 1,3-Cyclopentanedione Sales Value, 2021–2032
6.7.2 South Korea 1,3-Cyclopentanedione Sales Value by Type (%), 2025 vs 2032
6.7.3 South Korea 1,3-Cyclopentanedione Sales Value by Application, 2025 vs 2032
6.8 Southeast Asia
6.8.1 Southeast Asia 1,3-Cyclopentanedione Sales Value, 2021–2032
6.8.2 Southeast Asia 1,3-Cyclopentanedione Sales Value by Type (%), 2025 vs 2032
6.8.3 Southeast Asia 1,3-Cyclopentanedione Sales Value by Application, 2025 vs 2032
6.9 India
6.9.1 India 1,3-Cyclopentanedione Sales Value, 2021–2032
6.9.2 India 1,3-Cyclopentanedione Sales Value by Type (%), 2025 vs 2032
6.9.3 India 1,3-Cyclopentanedione Sales Value by Application, 2025 vs 2032
7 Company Profiles
7.1 BTC Pharmaceuticals Technology
7.1.1 BTC Pharmaceuticals Technology Company Information
7.1.2 BTC Pharmaceuticals Technology Introduction and Business Overview
7.1.3 BTC Pharmaceuticals Technology 1,3-Cyclopentanedione Sales, Revenue, Price and Gross Margin (2021–2026)
7.1.4 BTC Pharmaceuticals Technology 1,3-Cyclopentanedione Product Offerings
7.1.5 BTC Pharmaceuticals Technology Recent Developments
7.2 Win-Win Chemical
7.2.1 Win-Win Chemical Company Information
7.2.2 Win-Win Chemical Introduction and Business Overview
7.2.3 Win-Win Chemical 1,3-Cyclopentanedione Sales, Revenue, Price and Gross Margin (2021–2026)
7.2.4 Win-Win Chemical 1,3-Cyclopentanedione Product Offerings
7.2.5 Win-Win Chemical Recent Developments
7.3 Hefei TNJ Chemical
7.3.1 Hefei TNJ Chemical Company Information
7.3.2 Hefei TNJ Chemical Introduction and Business Overview
7.3.3 Hefei TNJ Chemical 1,3-Cyclopentanedione Sales, Revenue, Price and Gross Margin (2021–2026)
7.3.4 Hefei TNJ Chemical 1,3-Cyclopentanedione Product Offerings
7.3.5 Hefei TNJ Chemical Recent Developments
7.4 Hangzhou Chempro Technology
7.4.1 Hangzhou Chempro Technology Company Information
7.4.2 Hangzhou Chempro Technology Introduction and Business Overview
7.4.3 Hangzhou Chempro Technology 1,3-Cyclopentanedione Sales, Revenue, Price and Gross Margin (2021–2026)
7.4.4 Hangzhou Chempro Technology 1,3-Cyclopentanedione Product Offerings
7.4.5 Hangzhou Chempro Technology Recent Developments
7.5 Tyger Scientific
7.5.1 Tyger Scientific Company Information
7.5.2 Tyger Scientific Introduction and Business Overview
7.5.3 Tyger Scientific 1,3-Cyclopentanedione Sales, Revenue, Price and Gross Margin (2021–2026)
7.5.4 Tyger Scientific 1,3-Cyclopentanedione Product Offerings
7.5.5 Tyger Scientific Recent Developments
7.6 Amadis Chemical
7.6.1 Amadis Chemical Company Information
7.6.2 Amadis Chemical Introduction and Business Overview
7.6.3 Amadis Chemical 1,3-Cyclopentanedione Sales, Revenue, Price and Gross Margin (2021–2026)
7.6.4 Amadis Chemical 1,3-Cyclopentanedione Product Offerings
7.6.5 Amadis Chemical Recent Developments
8 Industry Chain Analysis
8.1 1,3-Cyclopentanedione Industrial Chain
8.2 1,3-Cyclopentanedione Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Key Suppliers of Raw Materials
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customer Analysis)
8.5 Sales Model and Sales Channelss
8.5.1 1,3-Cyclopentanedione Sales Model
8.5.2 Sales Channels
8.5.3 1,3-Cyclopentanedione Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global 1,3-Cyclopentanedione market was valued at US$ 27.42 million in 2025 and is anticipated to reach US$ 37.9 million by 2032, at a CAGR of 4.8% from 2026 to 2032.
Published Date: 2026-04-21
Pages: 133
USD 2900.00
(Single User License)
The global 1,3-Cyclopentanedione market is projected to grow from US$ 26.3 million in 2024 to US$ 36.3 million by 2031, at a CAGR of 4.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-22
Pages: 132
USD 4900.00
(Single User License)
The global market for 1,3-Cyclopentanedione was estimated to be worth US$ 26.3 million in 2024 and is forecast to a readjusted size of US$ 36.3 million by 2031 with a CAGR of 4.8% during the forecast period 2025-2031.
Published Date: 2025-02-15
Pages: 93
USD 3950.00
(Single User License)
The global market for 1,3-Cyclopentanedione was valued at US$ 26.3 million in the year 2024 and is projected to reach a revised size of US$ 36.3 million by 2031, growing at a CAGR of 4.8% during the forecast period.
Published Date: 2025-02-15
Pages: 93
USD 2900.00
(Single User License)
The global 1,3-Cyclopentanedione market size was US$ 26.3 million in 2024 and is forecast to a readjusted size of US$ 36.3 million by 2031 with a CAGR of 4.8% during the forecast period 2025-2031.
Published Date: 2025-02-15
Pages: 80
USD 4250.00
(Single User License)
1,3-Cyclopentanedione (CAS 3859-41-4) is a white to brown crystalline powder with a molecular formula of C5H6O2, mainly used as an intermediate in organic synthesis.
Published Date: 2024-04-18
Pages: 87
USD 4900.00
(Single User License)
1,3-Cyclopentanedione (CAS 3859-41-4) is a white to brown crystalline powder with a molecular formula of C5H6O2, mainly used as an intermediate in organic synthesis.
Published Date: 2024-01-17
Pages: 87
USD 2900.00
(Single User License)
1,3-Cyclopentanedione (CAS 3859-41-4) is a white to brown crystalline powder with a molecular formula of C5H6O2, mainly used as an intermediate in organic synthesis.
Published Date: 2024-01-06
Pages: 97
USD 3950.00
(Single User License)
The global 1,3-Cyclopentanedione market was valued at US$ 27.42 million in 2025 and is anticipated to reach US$ 37.9 million by 2032, at a CAGR of 4.8% from 2026 to 2032.
Published: 2026-04-21
Pages: 133
The global 1,3-Cyclopentanedione market is projected to grow from US$ 26.3 million in 2024 to US$ 36.3 million by 2031, at a CAGR of 4.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-22
Pages: 132
The global market for 1,3-Cyclopentanedione was estimated to be worth US$ 26.3 million in 2024 and is forecast to a readjusted size of US$ 36.3 million by 2031 with a CAGR of 4.8% during the forecast period 2025-2031.
Published: 2025-02-15
Pages: 93
The global market for 1,3-Cyclopentanedione was valued at US$ 26.3 million in the year 2024 and is projected to reach a revised size of US$ 36.3 million by 2031, growing at a CAGR of 4.8% during the forecast period.
Published: 2025-02-15
Pages: 93
The global 1,3-Cyclopentanedione market size was US$ 26.3 million in 2024 and is forecast to a readjusted size of US$ 36.3 million by 2031 with a CAGR of 4.8% during the forecast period 2025-2031.
Published: 2025-02-15
Pages: 80
1,3-Cyclopentanedione (CAS 3859-41-4) is a white to brown crystalline powder with a molecular formula of C5H6O2, mainly used as an intermediate in organic synthesis.
Published: 2024-04-18
Pages: 87
1,3-Cyclopentanedione (CAS 3859-41-4) is a white to brown crystalline powder with a molecular formula of C5H6O2, mainly used as an intermediate in organic synthesis.
Published: 2024-01-17
Pages: 87
1,3-Cyclopentanedione (CAS 3859-41-4) is a white to brown crystalline powder with a molecular formula of C5H6O2, mainly used as an intermediate in organic synthesis.
Published: 2024-01-06
Pages: 97
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now